Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials. It operates in China, Singapore, the United States, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. The company was founded in 2002 and is based in Beijing, China. more
Time Frame | LSB | Sector | S&P500 |
---|---|---|---|
1-Week Return | 18.64% | -2.12% | -3% |
1-Month Return | 12.98% | -3.42% | -0.73% |
3-Month Return | -61.56% | -11.13% | 2.87% |
6-Month Return | -49.4% | -5.74% | 7.17% |
1-Year Return | -34.22% | 3.97% | 25.31% |
3-Year Return | -96.95% | 1.05% | 28.38% |
5-Year Return | -68.78% | 34.37% | 81.89% |
Mar '21 | Mar '22 | Mar '23 | Mar '24 | |||
---|---|---|---|---|---|---|
Total Revenue | 257.02M | 502.95M | 687.20M | 573.42M | [{"date":"2021-03-31","value":37.4,"profit":true},{"date":"2022-03-31","value":73.19,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":83.44,"profit":true}] | |
Cost of Revenue | 59.66M | 117.07M | 153.36M | 117.69M | [{"date":"2021-03-31","value":38.9,"profit":true},{"date":"2022-03-31","value":76.33,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":76.74,"profit":true}] | |
Gross Profit | 197.36M | 385.88M | 533.84M | 455.73M | [{"date":"2021-03-31","value":36.97,"profit":true},{"date":"2022-03-31","value":72.28,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":85.37,"profit":true}] | |
Gross Margin | 76.79% | 76.72% | 77.68% | 79.48% | [{"date":"2021-03-31","value":96.62,"profit":true},{"date":"2022-03-31","value":96.54,"profit":true},{"date":"2023-03-31","value":97.74,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |
Operating Expenses | 319.68M | 549.18K | 647.15M | 901.56M | [{"date":"2021-03-31","value":35.46,"profit":true},{"date":"2022-03-31","value":0.06,"profit":true},{"date":"2023-03-31","value":71.78,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] | |
Operating Income | (125.85M) | (549.18K) | (139.38M) | (445.83M) | [{"date":"2021-03-31","value":-12584773700,"profit":false},{"date":"2022-03-31","value":-54918000,"profit":false},{"date":"2023-03-31","value":-13938235100,"profit":false},{"date":"2024-03-31","value":-44583250200,"profit":false}] | |
Total Non-Operating Income/Expense | (78.21M) | 15.17M | (35.82M) | (53.71M) | [{"date":"2021-03-31","value":-515.45,"profit":false},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-236.07,"profit":false},{"date":"2024-03-31","value":-353.93,"profit":false}] | |
Pre-Tax Income | (174.37M) | (545.73K) | (144.35M) | (455.19M) | [{"date":"2021-03-31","value":-17437199700,"profit":false},{"date":"2022-03-31","value":-54572700,"profit":false},{"date":"2023-03-31","value":-14434560100,"profit":false},{"date":"2024-03-31","value":-45519347800,"profit":false}] | |
Income Taxes | 17.45M | 4.94M | 1.13M | (21.73M) | [{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":28.29,"profit":true},{"date":"2023-03-31","value":6.49,"profit":true},{"date":"2024-03-31","value":-124.49,"profit":false}] | |
Income After Taxes | (191.83M) | (5.48M) | (145.48M) | (433.46M) | [{"date":"2021-03-31","value":-19182624200,"profit":false},{"date":"2022-03-31","value":-548284900,"profit":false},{"date":"2023-03-31","value":-14547910500,"profit":false},{"date":"2024-03-31","value":-43346487100,"profit":false}] | |
Income From Continuous Operations | (191.83M) | (106.00M) | (145.48M) | (433.46M) | [{"date":"2021-03-31","value":-19182624200,"profit":false},{"date":"2022-03-31","value":-10600440100,"profit":false},{"date":"2023-03-31","value":-14547910500,"profit":false},{"date":"2024-03-31","value":-43346487100,"profit":false}] | |
Income From Discontinued Operations | - | - | - | - | [{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] | |
Net Income | (191.83M) | (545.73K) | (145.48M) | (433.46M) | [{"date":"2021-03-31","value":-19182624200,"profit":false},{"date":"2022-03-31","value":-54572700,"profit":false},{"date":"2023-03-31","value":-14547910500,"profit":false},{"date":"2024-03-31","value":-43346487100,"profit":false}] | |
EPS (Diluted) | - | 0.42 | - | (0.17) | [{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-41.15,"profit":false}] | |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
LSB | |
---|---|
ROA (LTM) | -13.85% |
ROE (LTM) | -65.99% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
LSB | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.20 |
P/B | 1.39 |
EV/R | 1.73 |
EV/Ebitda | NM |
LakeShore Biopharma Co., Ltd (LSB) share price today is $2.96
Yes, Indians can buy shares of LakeShore Biopharma Co., Ltd (LSB) on Vested. To buy LakeShore Biopharma Co., Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LSB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of LakeShore Biopharma Co., Ltd (LSB) via the Vested app. You can start investing in LakeShore Biopharma Co., Ltd (LSB) with a minimum investment of $1.
You can invest in shares of LakeShore Biopharma Co., Ltd (LSB) via Vested in three simple steps:
The 52-week high price of LakeShore Biopharma Co., Ltd (LSB) is $11.2. The 52-week low price of LakeShore Biopharma Co., Ltd (LSB) is $1.88.
The price-to-earnings (P/E) ratio of LakeShore Biopharma Co., Ltd (LSB) is
The price-to-book (P/B) ratio of LakeShore Biopharma Co., Ltd (LSB) is 1.39
The dividend yield of LakeShore Biopharma Co., Ltd (LSB) is 0.00%
The market capitalization of LakeShore Biopharma Co., Ltd (LSB) is $114.29M
The stock symbol (or ticker) of LakeShore Biopharma Co., Ltd is LSB